Carl Desantis - 03 Nov 2021 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: INBP
Reported as of: 03 Nov 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Nov 2021, 12:16:43 UTC
Prior SEC filing: 15 Jun 2021
Next SEC filing: 02 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Carl DeSantis

Key filing fact

Carl Desantis filed Form 4 for INTEGRATED BIOPHARMA INC (INBP) on 04 Nov 2021.

Key facts

This page summarizes Carl Desantis's Form 4 filing for INTEGRATED BIOPHARMA INC (INBP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Nov 2021, 12:16.

Change

Previous filing in this sequence was filed on 15 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INBP transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 03 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date").

Footnote F2

The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022.